DOCSLIB.ORG

EUROPEAN COMMISSION Brussels, 28 April 2020 REGISTER of FOOD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
EUROPEAN COMMISSION Brussels, 28 April 2020 REGISTER of FOOD EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Food and feed safety, innovation Food processing technologies and novel foods Brussels, 28 April 2020 REGISTER OF FOOD ENZYMES TO BE CONSIDERED FOR INCLUSION IN THE UNION LIST Article 17 of Regulation (EC) No 1332/20081 provides for the establishment of a Register of all food enzymes to be considered for inclusion in the Union list. In accordance with that Article, the Register includes all applications which were submitted within the initial period fixed by that Regulation and which comply with the validity criteria laid down in accordance with Article 9(1) of (EC) No 1331/2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings2. The Register therefore lists all valid food enzyme applications submitted until 11 March 2015 except those withdrawn by the applicant before that date. Applications submitted after that date are not included in the Register but will be processed in accordance with the Common Authorisation Procedure. The entry of a food enzyme in the Register specifies the identification, the name, the source of the food enzyme as provided by the applicant and the EFSA question number under which the status of the Authority’s assessment can be followed3. As defined by Article 3 of Regulation (EC) No 1332/2008, ‘food enzyme’ subject to an entry in the Register, refers to a product that may contain more than one enzyme capable of catalysing a specific biochemical reaction. In the assessment process, such a food enzyme may be linked with several EFSA question numbers. The present Register is not a list of authorised food enzymes. The enzymes in the Register are not authorised at Union level and have not necessarily already been evaluated by the Authority. Those enzymes that already have been evaluated by the Authority, did not all get a positive opinion. That does not affect the Register but will be taken into account at the time of adoption of the Union List in accordance with Article 7 of Regulation (EC) No 1331/2008. 1 Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on food enzymes and amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97 (OJ L 354, 31.12.2008, p.7) 2 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings (OJ L 354, 31.12.2008, p 1-6) 3 http://registerofquestions.efsa.europa.eu/roqFrontend/ListOfQuestionsNoLogin?2&unit=FIP&rawPanel=CEF&foodsectorarea=12 1 | 21 The Union List of food enzymes will be adopted once the Authority has issued an opinion on each food enzyme included in the Register in accordance with the procedure laid down in article 3 of Regulation (EC) No 1331/2008. Without prejudice to other applicable Union legislation, including Regulation (EC) No 178/20024, until the date of application of the Union list of food enzymes, national provisions in force concerning the placing on the market and use of food enzymes and food produced with food enzymes continue to apply in the Member States, in accordance with Article 24 of the Regulation on Food Enzymes. As per Article 4 of the Regulation on Food Enzymes, from the date of application of the Union list, only food enzymes included in that list may be placed on the EU market as such and used in foods, in accordance with the specifications and conditions of use provided for in the list. This Register was prepared by Commission services and does not commit the European Commission. Only the Court of Justice of the European Union is competent to authoritatively interpret Union law. 4 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety, OJ L 31, 1.2.2002, p. 1. 2 | 21 Name of 5 Name of the the IUBMB Name of the food production productio EFSA Q Commiss number Systematic name enzyme as organism as n strain Number ion ID (EC) submitted submitted as submitted 2013/19 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Aspergillus ZGL EFSA-Q- oxidoreductase niger 2013-01005 2013/22 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Aspergillus not EFSA-Q- oxidoreductase niger available 2013-01018 2015/151 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Aspergillus NZYM-KA EFSA-Q- oxidoreductase niger 2016-00134 2015/179 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Aspergillus DP-Aze23 EFSA-Q- oxidoreductase niger 2016-00144 2013/06 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Aspergillus NZYM-KP EFSA-Q- oxidoreductase oryzae 2013-00687 2015/121 1.1.3.4 β-D-glucose:oxygen 1- Glucose oxidase Penicillium PGO 19- EFSA-Q- oxidoreductase chrysogenum 162 2016-00533 2015/47 1.1.3.5 D-hexose:oxygen 1- Hexose oxidase Hansenula DP-Jza21 EFSA-Q- oxidoreductase polymorpha 2015-00406 2015/96 1.10.3.2 Benzenediol:oxygen Laccase Trametes AE-OR EFSA-Q- oxidoreductase hirusta 2015-00694 2015/105 1.10.3.3 L-ascorbate:oxygen L-Ascorbate Cucurbita not EFSA-Q- oxidoreductase oxidase pepo and applicable 2015-00825 Cucurbita moschata 2015/65 1.11.1.6 Hydrogen- Catalase Aspergillus AE-CN EFSA-Q- peroxide:hydrogen- niger 2015-00449 peroxide oxidoreductase 2015/119 1.11.1.6 Hydrogen- Catalase Aspergillus CTS 2093 EFSA-Q- peroxide:hydrogen- niger 2016-00532 peroxide oxidoreductase 2015/185 1.11.1.6 Hydrogen- Catalase Aspergillus DP-Azw58 EFSA-Q- peroxide:hydrogen- niger 2016-00274 peroxide oxidoreductase 2015/198 1.11.1.6 Hydrogen- Catalase Extracts of not EFSA-Q- peroxide:hydrogen- hog (pig) liver applicable 2017-00406 peroxide oxidoreductase 5 Identification number of the International Union of Biochemistry and Molecular Biology. 3 | 21 2015/158 1.11.1.6 Hydrogen- Catalase Porcine livers not EFSA-Q- peroxide:hydrogen- applicable 2016-00101 peroxide oxidoreductase 2015/26 1.11.1.7 Phenolic Peroxidase Aspergillus MOX EFSA-Q- donor:hydrogen- niger 2015-00274 peroxide oxidoreductase 2015/186 1.11.1.7 Phenolic Peroxidase Bovine milk - not EFSA-Q- donor:hydrogen- bovine applicable 2017-00041 peroxide cheese whey oxidoreductase - bovine colostrum 2013/10 1.11.1.7 Phenolic Peroxidase Soy bean not EFSA-Q- donor:hydrogen- hulls applicable 2013-00897 peroxide oxidoreductase 2015/169 2.3.2.13 Protein- Transglutaminase Streptomyces DSM EFSA-Q- glutamine:amine γ- mobaraensis 40587 2016-00657 glutamyltransferase 2015/188 2.3.2.13 Protein- Transglutaminase Streptomyces DSM EFSA-Q- glutamine:amine γ- mobaraensis 40587 2017-00615 glutamyltransferase 2015/10 2.3.2.13 Protein- Transglutaminase Streptoverticil S-8112 EFSA-Q- glutamine:amine γ- lium 2015-00095 glutamyltransferase mobaraense 2015/171 2.4.1.18 (1→4)-α-D- 1,4-alpha-Glucan Bacillus BR151 EFSA-Q- glucan:(1→4)-α-D- branching enzyme subtilis (pUAQ2) 2017-00408 glucan 6-α-D-[(1→4)-α- D-glucano]-transferase 2015/147 2.4.1.18 (1→4)-α-D- 1,4-alpha-Glucan Geobacillus TRBE14 EFSA-Q- glucan:(1→4)-α-D- branching enzyme stearothermo 2016-00100 glucan 6-α-D-[(1→4)-α- philus D-glucano]-transferase 2015/163 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Bacillus not EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase circulans available 2016-00523 glucan 4-alpha-D-[(1- >4)-alpha-D-glucano]- transferase (cyclizing) 2015/201 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Escherichia WCM105x EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase coli pCM703 2016-00530 glucan 4-alpha-D-[(1- >4)-alpha-D-glucano]- transferase (cyclizing) 2015/202 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Escherichia WCM105x EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase coli pCM6420 2016-00531 glucan 4-alpha-D-[(1- >4)-alpha-D-glucano]- 4 | 21 transferase (cyclizing) 2015/03 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Geobacillus St-88 EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase stearothermo 2015-00230 glucan 4-alpha-D-[(1- philus >4)-alpha-D-glucano]- transferase (cyclizing) 2015/88 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Geobacillus AE-KCGT EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase stearothermo 2015-00081 glucan 4-alpha-D-[(1- philus >4)-alpha-D-glucano]- transferase (cyclizing) 2015/175 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Geobacillus not EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase stearothermo available 2016-00863 glucan 4-alpha-D-[(1- philus >4)-alpha-D-glucano]- transferase (cyclizing) 2015/89 2.4.1.19 (1->4)-alpha-D- Cyclomaltodextrin Paenibacillus AE-CGT EFSA-Q- glucan:(1->4)-alpha-D- glucanotransferase alginolyticus 2015-00082 glucan 4-alpha-D-[(1- >4)-alpha-D-glucano]- transferase (cyclizing) 2015/199 2.4.1.25 (1→4)-α-D- 4-alpha- Bacillus MAS EFSA-Q- glucan:(1→4)-α-D- glucanotransferase amyloliquefac 2017-00405 glucan 4-α-D- iens glycosyltransferase 2015/128 2.4.1.25 (1→4)-α-D- 4-alpha- Geobacillus AE-SAS EFSA-Q- glucan:(1→4)-α-D- glucanotransferase pallidus 2016-00033 glucan 4-α-D- glycosyltransferase 2015/157 2.4.1.14 Sucrose:(1→6)[(1→3)]- Alternansucrase Leuconostoc NRRL B- EFSA-Q- 0 α-D-glucan 6(3)-α-D- citreum 30894 2016-00209 glucosyltransferase 2014/04 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus LFS EFSA-Q- acylhydrolase lipase niger 2014-00325 2015/22 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus NZYM-DB EFSA-Q- acylhydrolase lipase niger 2015-00234 2015/28 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus AE-L EFSA-Q- acylhydrolase lipase niger 2015-00276 2015/144 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus FL 108SC EFSA-Q- acylhydrolase lipase niger 2016-00099 2015/154 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus NL 151 EFSA-Q- acylhydrolase lipase niger 2016-00654 2015/63 3.1.1.3 Triacylglycerol Triacylglycerol Aspergillus FL100SC EFSA-Q- acylhydrolase lipase niger agg.
Load more

Recommended publications
  • Microbial Enzymes and Their Applications in Industries and Medicine
    BioMed Research International Microbial Enzymes and Their Applications in Industries and Medicine Guest Editors: Periasamy Anbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Microbial Enzymes and Their Applications in Industries and Medicine BioMed Research International Microbial Enzymes and Their Applications in Industries and Medicine Guest Editors: Periasamy Anbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Copyright © 2013 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “BioMed Research International.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Contents Microbial Enzymes and Their Applications in Industries and Medicine,PeriasamyAnbu, Subash C. B. Gopinath, Arzu Coleri Cihan, and Bidur Prasad Chaulagain Volume 2013, Article ID 204014, 2 pages Effect of C/N Ratio and Media Optimization through Response Surface Methodology on Simultaneous Productions of Intra- and Extracellular Inulinase and Invertase from Aspergillus niger ATCC 20611, Mojdeh Dinarvand, Malahat Rezaee, Malihe Masomian, Seyed Davoud Jazayeri, Mohsen Zareian, Sahar Abbasi, and Arbakariya B. Ariff Volume 2013, Article ID 508968, 13 pages A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond, Neelam Gurung, Sumanta Ray, Sutapa Bose, and Vivek Rai Volume 2013, Article
    [Show full text]
  • IUB No. Enzyme Name Source Approved in EC 1,4-Alpha-Glucan Bacillus Subtilis JECFA, Denmark, France, Brazil, 2.4.1.18 Branching Enzyme USA (GRAS Notice No
    IUB No. Enzyme name Source Approved in EC 1,4-alpha-glucan Bacillus subtilis JECFA, Denmark, France, Brazil, 2.4.1.18 branching enzyme USA (GRAS Notice No. GRN 00274) Alpha-acetolactate Bacillus subtilis expressed in USA 21 CFR 173.115 decarboxylase Bacillus brevis EC 3.2.1.1 Alpha amylase Aspergillus niger Australia/New Zealand, Canada, France, Brazil, Mexico, USA (GRN 89) Aspergillus oryzae Australia/New Zealand, Canada, France, Brazil, Mexico, USA (GRN 90) Bacillus amyloliquefaciens Australia and New Zealand, Canada, Mexico, Brazil, USA 21 CFR 184.1148 Bacillus licheniformis Belgium, France, China, Japan, Denmark, Australia and New Zealand, Canada, Mexico, Brazil Bacillus licheniformis expressed Australia/New Zealand, Canada, in Bacillus licheniformis France, Brazil, Denmark, Mexico, USA GRAS Notice No. GRN 000079, JECFA Bacillus licheniformis and GRAS Notice No. GRN 00022, Bacillus amyloliquefaciens Brazil, Mexico expressed in Bacillus licheniformis Bacillus amyloliquefaciens Brazil, Denmark, France expressed in Bacillus licheniformis Bacillus megaterium expressed JECFA, Canada, Brazil, Mexico in Bacillus subtilis Bacillus stearothermophilus JECFA, Canada, Brazil, Mexico, USA 21 CFR 184.1012 Bacillus stearothermophilus Australia/New Zealand, Canada, expressed in Bacillus France, Brazil, Denmark, Mexico, licheniformis Japan, GRAS Notice No. GRN 000024 Bacillus stearothermophilus Australia/New Zealand, Canada, expressed in Bacillus subtilis France, Brazil, Denmark, Mexico Bacillus stearothermophilus Australia/New Zealand, Canada, (Geobacillus France, Europa, Brazil, Mexico, stearothermophilus) USA (GRN 594) Bacillus subtilis Australia and New Zealand, Canada, Mexico, Brazil, USA 21 CFR 184.1148 Rhizopus delemar Brazil Rhizopus oryzae Brazil, Mexico, USA GRAS Notice No. GRN 000090 Thermoccocales expressed in Brazil, USA (GRN126) Pseudomonas fluorecens Rhizomucor pusillus expressed Brazil, Denmark, France, Mexico, in Aspergillus niger Australia and New Zealand.
    [Show full text]
  • In Vitro Inhibition of HIV-1 Proteinase by Cerulenin
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 261, number 2, 373-377 FEBS 08165 February 1990 In vitro inhibition of HIV-1 proteinase by cerulenin Karin Moelling, Thomas Schulze, Marie-Theres Knoop, John Kay +, Raymond Jupp +, George Nicolaou* and Laurence H. Pearl* Max-Planck lnstitut fiir Molekular Genetik, lhnestrasse 73, D-IO00 Berlin 33, FRG, +Department of Biochemistry, University College of Wales, PO Box 903, Cardiff CFl 1ST, UK and *Department of Biochemistry, University College London, Gower Street, London WCIE 6BT, UK Received 13 October 1989; revised version received 18 December 1989 Retroviruses encode proteinases necessary for the proteolytic processing of the viral gag and gag-pol precursor proteins. These enzymes have been shown to be structurally and functionally related to aspartyl proteinases such as pepsin and renin. Cerulenin is a naturally occurring antibiotic, commonly used as an inhibitor of fatty acid synthesis. Cerulenin has been observed to inhibit production of Rous sarcoma virus and murine leukae- mia virus by infected cells, possibly by interfering with proteolytic processing of viral precursor proteins. We show here that cerulenin inhibits the action of the HIV-1 proteinase in vitro, using 3 substrates: a synthetic heptapeptide (SQNYPIV) which corresponds to the sequence at the HIV-I gag p17/p24 junction, a bacterially expressed gag precursor, and purified 66 kDa reverse transcriptase. Inhibition of cleavage by HIV-1 proteinase required preincubation with cerulenin. Cerulenin also inactivates endothiapepsin, a well-characterised fungal aspartyl proteinase, sug- gesting that the action of cerulenin is a function of the common active site structure of the retroviral and aspartic proteinases.
    [Show full text]
  • Membrane Proteins • Cofactors – Plimstex • Membranes • Dna • Small Molecules/Gas • Large Complexes
    Structural mass spectrometry hydrogen/deuterium exchange Petr Man Structural Biology and Cell Signalling Institute of Microbiology, Czech Academy of Sciences Structural biology methods Low-resolution methods High-resolution methods Rigid SAXS IR Raman CD ITC MST Cryo-EM AUC SPR MS X-ray crystallography Chemical cross-linking H/D exchange Native ESI + ion mobility Oxidative labelling Small Large NMR Dynamic Structural biology approaches Simple MS, quantitative MS Cross-linking, top-down, native MS+dissociation native MS+ion mobility Cross-linking Structural MS What can we get using mass spectrometry IM – ion mobility CXL – chemical cross-linking AP – afinity purification OFP – oxidative footprinting HDX – hydrogen/deuterium exchange ISOTOPE EXCHANGE IN PROTEINS 1H 2H 3H occurence [%] 99.988 0.0115 trace 5 …Kaj Ulrik Linderstrøm-Lang „Cartesian diver“ Proteins are migrating in tubes with density gradient until they stop at the point where the densities are equal 1H 2H 3H % 99.9885 0.0115 trace density [g/cm3] 1.000 1.106 1.215 Methods of detection IR: β-: NMR: 1 n = 1.6749 × 10-27 kg MS: 1H 2H 3H výskyt% [%] 99.9885 0.0115 trace hustotadensity vody [g/cm [g/cm3] 3] 1.000 1.106 1.215 jadernýspinspin ½+ 1+ ½+ mass [u] 1.00783 2.01410 3.01605 Factors affecting H/D exchange hydrogen bonding solvent accessibility Factors affecting H/D exchange Side chains (acidity, steric shielding) Bai et al.: Proteins (1993) Glasoe, Long: J. Phys. Chem. (1960) Factors affecting H/D exchange – side chain effects Inductive effect – electron density is Downward shift due to withdrawn from peptide steric hindrance effect of bond (S, O).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS Et Al
    US 2016.0346364A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS et al. (43) Pub. Date: Dec. 1, 2016 (54) MEDICAMENT AND METHOD FOR (52) U.S. Cl. TREATING INNATE IMMUNE RESPONSE CPC ........... A61K 38/488 (2013.01); A61K 38/482 DISEASES (2013.01); C12Y 304/23019 (2013.01); C12Y 304/21026 (2013.01); C12Y 304/23018 (71) Applicant: DSM IPASSETS B.V., Heerlen (NL) (2013.01); A61K 9/0053 (2013.01); C12N 9/62 (2013.01); A23L 29/06 (2016.08); A2ID 8/042 (72) Inventors: Maaike Johanna BRUINS, Kaiseraugst (2013.01); A23L 5/25 (2016.08); A23V (CH); Luppo EDENS, Kaiseraugst 2002/00 (2013.01) (CH); Lenneke NAN, Kaiseraugst (CH) (57) ABSTRACT (21) Appl. No.: 15/101,630 This invention relates to a medicament or a dietary Supple (22) PCT Filed: Dec. 11, 2014 ment comprising the Aspergillus niger aspergilloglutamic peptidase that is capable of hydrolyzing plant food allergens, (86). PCT No.: PCT/EP2014/077355 and more particularly, alpha-amylase/trypsin inhibitors, thereby treating diseases due to an innate immune response S 371 (c)(1), in humans, and/or allowing to delay the onset of said (2) Date: Jun. 3, 2016 diseases. The present invention relates to the discovery that (30) Foreign Application Priority Data the Aspergillus niger aspergilloglutamic peptidase is capable of hydrolyzing alpha-amylase/trypsin inhibitors that are Dec. 11, 2013 (EP) .................................. 13196580.8 present in wheat and related cereals said inhibitors being strong inducers of innate immune response. Furthermore, Publication Classification the present invention relates to a method for hydrolyzing alpha-amylase/trypsin inhibitors comprising incubating a (51) Int.
    [Show full text]
  • Application of Plant Proteolytic Enzymes for Tenderization of Rabbit Meat
    Biotechnology in Animal Husbandry 34 (2), p 229-238 , 2018 ISSN 1450-9156 Publisher: Institute for Animal Husbandry, Belgrade-Zemun UDC 637.5.039'637.55'712 https://doi.org/10.2298/BAH1802229D APPLICATION OF PLANT PROTEOLYTIC ENZYMES FOR TENDERIZATION OF RABBIT MEAT Maria Doneva, Iliana Nacheva, Svetla Dyankova, Petya Metodieva, Daniela Miteva Institute of Cryobiology and Food Technology, Cherni Vrah 53, 1407, Sofia, Bulgaria Corresponding author: Maria Doneva, e-mail: [email protected] Original scientific paper Abstract: The purpose of this study is to assess the tenderizing effect of plant proteolytic enzymes upon raw rabbit meat. Tests are performed on rabbit meat samples treated with papain and two vegetal sources of natural proteases (extracts of kiwifruit and ginger root). Two variants of marinade solutions are prepared from each vegetable raw materials– 50% (w/w) and 100 % (w/w), with a duration of processing 2h, 24h, and 48h. Changes in the following physico- chemical characteristics of meat have been observed: pH, water-holding capacity, cooking losses and quantity of free amino acids. Differences in values of these characteristics have been observed, both between control and test samples, as well as depending of treatment duration. For meat samples marinated with papain and ginger extracts, the water-holding capacity reached to 6.74 ± 0.04 % (papain), 5.58 ± 0.09 % (variant 1) and 6.80 ± 0.11 % (variant 2) after 48 hours treatment. In rabbit meat marinated with kiwifruit extracts, a significant increase in WHC was observed at 48 hours, 3.37 ± 0.07 (variant 3) and 6.84 ± 0.11 (variant 4).
    [Show full text]
  • Plant Protease Inhibitors: a Defense Strategy in Plants
    Biotechnology and Molecular Biology Review Vol. 2 (3), pp. 068-085, August 2007 Available online at http://www.academicjournals.org/BMBR ISSN 1538-2273 © 2007 Academic Journals Standard Review Plant protease inhibitors: a defense strategy in plants Huma Habib and Khalid Majid Fazili* Department of Biotechnology, The University of Kashmir, P/O Naseembagh, Hazratbal, Srinagar -190006, Jammu and Kashmir, India. Accepted 7 July, 2007 Proteases, though essentially indispensable to the maintenance and survival of their host organisms, can be potentially damaging when overexpressed or present in higher concentrations, and their activities need to be correctly regulated. An important means of regulation involves modulation of their activities through interaction with substances, mostly proteins, called protease inhibitors. Some insects and many of the phytopathogenic microorganisms secrete extracellular enzymes and, in particular, enzymes causing proteolytic digestion of proteins, which play important roles in pathogenesis. Plants, however, have also developed mechanisms to fight these pathogenic organisms. One important line of defense that plants have to fight these pathogens is through various inhibitors that act against these proteolytic enzymes. These inhibitors are thus active in endogenous as well as exogenous defense systems. Protease inhibitors active against different mechanistic classes of proteases have been classified into different families on the basis of significant sequence similarities and structural relationships. Specific protease inhibitors are currently being overexpressed in certain transgenic plants to protect them against invaders. The current knowledge about plant protease inhibitors, their structure and their role in plant defense is briefly reviewed. Key words: Proteases, enzymes, protease inhibitors, serpins, cystatins, pathogens, defense. Table of content 1.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips Et Al
    USOO598.1835A United States Patent (19) 11 Patent Number: 5,981,835 Austin-Phillips et al. (45) Date of Patent: Nov. 9, 1999 54) TRANSGENIC PLANTS AS AN Brown and Atanassov (1985), Role of genetic background in ALTERNATIVE SOURCE OF Somatic embryogenesis in Medicago. Plant Cell Tissue LIGNOCELLULOSC-DEGRADING Organ Culture 4:107-114. ENZYMES Carrer et al. (1993), Kanamycin resistance as a Selectable marker for plastid transformation in tobacco. Mol. Gen. 75 Inventors: Sandra Austin-Phillips; Richard R. Genet. 241:49-56. Burgess, both of Madison; Thomas L. Castillo et al. (1994), Rapid production of fertile transgenic German, Hollandale; Thomas plants of Rye. Bio/Technology 12:1366–1371. Ziegelhoffer, Madison, all of Wis. Comai et al. (1990), Novel and useful properties of a chimeric plant promoter combining CaMV 35S and MAS 73 Assignee: Wisconsin Alumni Research elements. Plant Mol. Biol. 15:373-381. Foundation, Madison, Wis. Coughlan, M.P. (1988), Staining Techniques for the Detec tion of the Individual Components of Cellulolytic Enzyme 21 Appl. No.: 08/883,495 Systems. Methods in Enzymology 160:135-144. de Castro Silva Filho et al. (1996), Mitochondrial and 22 Filed: Jun. 26, 1997 chloroplast targeting Sequences in tandem modify protein import specificity in plant organelles. Plant Mol. Biol. Related U.S. Application Data 30:769-78O. 60 Provisional application No. 60/028,718, Oct. 17, 1996. Divne et al. (1994), The three-dimensional crystal structure 51 Int. Cl. ............................. C12N 15/82; C12N 5/04; of the catalytic core of cellobiohydrolase I from Tricho AO1H 5/00 derma reesei. Science 265:524-528.
    [Show full text]
  • Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin
    Int. J. Mol. Sci. 2015, 16, 19184-19194; doi:10.3390/ijms160819184 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin Alwin M. Hartman 1,†, Milon Mondal 1,†, Nedyalka Radeva 2, Gerhard Klebe 2 and Anna K. H. Hirsch 1,* 1 Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands; E-Mails: [email protected] (A.M.H.); [email protected] (M.M.) 2 Institute of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany; E-Mails: [email protected] (N.R.); [email protected] (G.K.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Fax: +31-50-363-4296. Academic Editor: John George Hardy Received: 1 May 2015 / Accepted: 6 July 2015 / Published: 14 August 2015 Abstract: Aspartic proteases are a class of enzymes that play a causative role in numerous diseases such as malaria (plasmepsins), Alzheimer’s disease (β-secretase), fungal infections (secreted aspartic proteases), and hypertension (renin). We have chosen endothiapepsin as a model enzyme of this class of enzymes, for the design, preparation and biochemical evaluation of a new series of inhibitors of endothiapepsin. Here, we have optimized a hit, identified by de novo structure-based drug design (SBDD) and DCC, by using structure-based design approaches focusing on the optimization of an amide–π interaction. Biochemical results are in agreement with SBDD.
    [Show full text]
  • Progress in the Field of Aspartic Proteinases in Cheese Manufacturing
    Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering Sirma Yegin, Peter Dekker To cite this version: Sirma Yegin, Peter Dekker. Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering. Dairy Science & Technology, EDP sciences/Springer, 2013, 93 (6), pp.565-594. 10.1007/s13594-013-0137-2. hal-01201447 HAL Id: hal-01201447 https://hal.archives-ouvertes.fr/hal-01201447 Submitted on 17 Sep 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Dairy Sci. & Technol. (2013) 93:565–594 DOI 10.1007/s13594-013-0137-2 REVIEW PAPER Progress in the field of aspartic proteinases in cheese manufacturing: structures, functions, catalytic mechanism, inhibition, and engineering Sirma Yegin & Peter Dekker Received: 25 February 2013 /Revised: 16 May 2013 /Accepted: 21 May 2013 / Published online: 27 June 2013 # INRA and Springer-Verlag France 2013 Abstract Aspartic proteinases are an important class of proteinases which are widely used as milk-coagulating agents in industrial cheese production. They are available from a wide range of sources including mammals, plants, and microorganisms.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Current IUBMB Recommendations on Enzyme Nomenclature and Kinetics$
    Perspectives in Science (2014) 1,74–87 Available online at www.sciencedirect.com www.elsevier.com/locate/pisc REVIEW Current IUBMB recommendations on enzyme nomenclature and kinetics$ Athel Cornish-Bowden CNRS-BIP, 31 chemin Joseph-Aiguier, B.P. 71, 13402 Marseille Cedex 20, France Received 9 July 2013; accepted 6 November 2013; Available online 27 March 2014 KEYWORDS Abstract Enzyme kinetics; The International Union of Biochemistry (IUB, now IUBMB) prepared recommendations for Rate of reaction; describing the kinetic behaviour of enzymes in 1981. Despite the more than 30 years that have Enzyme passed since these have not subsequently been revised, though in various respects they do not nomenclature; adequately cover current needs. The IUBMB is also responsible for recommendations on the Enzyme classification naming and classification of enzymes. In contrast to the case of kinetics, these recommenda- tions are kept continuously up to date. & 2014 The Author. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/). Contents Introduction...................................................................75 Kinetics introduction...........................................................75 Introduction to enzyme nomenclature ................................................76 Basic definitions ................................................................76 Rates of consumption and formation .................................................76 Rate of reaction .............................................................76
    [Show full text]